VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > EIQ signs first hospital deal just weeks after.......

<< Previous

Bullboard Posts

Next >>

Comment by G1945Von Nov 19, 2024 11:26am

64 Views

Post# 36319836

RE:EIQ signs first hospital deal just weeks after.......

Mp2050 wrote: Some might find this an interesting read...
Shame VPT can't get traction quick enough.
Any one know what is the anticipated rebate per use to VPT?

EIQ signs first hospital deal just weeks after successful US FDA approval

Fingers crossed and good luck to all holders.